Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial

OBJECTIVES: To evaluate the 2-year clinical effectiveness of two gradual tapering strategies. The first strategy consisted of tapering the conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) first (i.e., methotrexate in ~90%), followed by the tumour necrosis factor inhibitor (TNF...

Descripción completa

Detalles Bibliográficos
Autores principales: van Mulligen, Elise, Weel, Angelique E, Hazes, J M, van der Helm-van Mil, Annette, de Jong, Pascal Hendrik Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456559/
https://www.ncbi.nlm.nih.gov/pubmed/32482645
http://dx.doi.org/10.1136/annrheumdis-2020-217485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456559/
https://www.ncbi.nlm.nih.gov/pubmed/32482645
http://dx.doi.org/10.1136/annrheumdis-2020-217485

Ejemplares similares